$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
索拉非尼多少钱一盒?
2025-10-19 11:44:20
Check Details
索拉非尼一盒可以服用多长时间?
2025-10-19 11:44:20
Check Details
索拉非尼一天可以吃几粒?
2025-10-19 11:44:20
Check Details
如何购买索拉非尼?
2025-10-19 11:44:20
Check Details
索拉非尼价格
2025-10-19 11:44:20
Check Details
索拉非尼说明书
2025-10-19 11:44:20
Check Details
英利达在国内买的到吗?
2025-10-19 11:44:20
Check Details
英利达怎么购买?
2025-10-19 11:44:20
Check Details
英利达服用方法
2025-10-19 11:44:20
Check Details
英利达最佳服药时间
2025-10-19 11:44:20
Check Details
英利达详细说明书
2025-10-19 11:44:20
Check Details
英利达效果怎么样?
2025-10-19 11:44:20
Check Details
1
2
...
2337
2338
2339
2340
2341
2342
2343
...
4156
4157
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Lorlatinib: Mechanism, Advantages, and Key Considerations of Third-Generation ALK Inhibitor Therapy in ALK-Positive NSCLC
2
Pemigatinib Side Effects Explained: Managing Adverse Reactions of FGFR-Targeted Therapy in Cholangiocarcinoma
3
Selpercatinib: Before or After Meals? A Complete Guide to RET-Targeted Therapy Administration
4
Mitotane for Adrenocortical Carcinoma: Dosing Guidelines and Therapeutic Drug Monitoring
5
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
6
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
7
Chemical Structure of Capivasertib: A Novel AKT Inhibitor
8
Capivasertib: An AKT Inhibitor for Breast and Prostate Cancer
9
Global Update 2026: Selumetinib (KOSELUGO) Expands Indication to Adult NF1-PN and Clinical Management Strategies
10
Lenvatinib Safety Guide: Baseline Assessment & Adverse Reaction Management
11
Inluriyo (Imlunestrant): Oral SERD for ER+/HER2- Breast Cancer with ESR1 Mutations
12
Idelalisib: Oral PI3Kδ Inhibitor for Relapsed/Refractory Hematologic Malignancies